AzTrials
AzTrials

InsomniaNCT02848859

Improving Sleep for Healthy Hearts

A study testing Go! to Sleep and General Sleep Education in people with Insomnia and Coronary Heart Disease, run by Brigham and Women's Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a pilot study randomizing patients with insomnia and coronary heart disease to either general sleep hygiene counseling and web-based cognitive behavioral therapy for insomnia versus general sleep hygiene counseling alone (followed by the cognitive behavioral therapy at a later date). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Insomnia, Coronary Heart Disease
What is being tested?
Go! to Sleep and General Sleep Education
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
34 participants
Where
1 siteUnited States
Study dates
Mar 2015to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • meet criteria for at least mild insomnia based on the Insomnia Severity Index questionnaire results
  • have established coronary disease defined by: a) prior myocardial infarction or a coronary artery revascularization procedure; b) angiographically documented stenosis (>70%) of a major coronary artery; or c) prior ischemic stroke without major functional impairment.
  • minimum age of 18 years old.

Who cannot join

  • no daily access to a computer with an internet connection
  • visual impairment preventing use of a computer
  • inability to read English
  • severe uncontrolled medical or psychiatric problems
  • heart failure with reduced ejection fraction <35%
  • high depressive symptoms (PHQ > 15)
Show all 12Show fewer
  • drowsy driving
  • >3 days per week use of hypnotic medications
  • known untreated sleep disordered breathing, narcolepsy, or restless leg syndrome
  • shift-workers
  • prior exposure to CBT-I treatment
  • dialysis patient

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Brigham and Womens Hospital

    Boston, Massachusetts, 02115

Other trials in United States

About this study

This is a pilot study randomizing patients with insomnia and coronary heart disease to either general sleep hygiene counseling and web-based cognitive behavioral therapy for insomnia versus general sleep hygiene counseling alone (followed by the cognitive behavioral therapy at a later date).

Read the detailed description

For this pilot study, the investigators will recruit up to 30 participants with insomnia and coronary heart disease. Another 30 patients will be recruited from another institution. Patients will be screened with a modified version of the Insomnia Severity Index (ISI), a brief self-report instrument validated for identifying insomnia. The investigators will modify the ISI to include exclusionary criteria. The investigators will randomize participants to 6 weeks of access to web based cognitive behavioral therapy for insomnia (wCBT-I) using an internet based CBT-I program plus education provided through access to the Harvard Sleep Education web site (which provides general sleep education information only) compared to 6 weeks of access to the Harvard Sleep Education web site, followed by access to the web-CBT program (a wait list control group). The investigators will test the hypothesis that use of wCBT-I improves sleep quality and sleep duration as measured by sleep diaries and the ISI. A secondary goal of the study is to assess the recruitment yields, retention and adherence rates.

Being tested
Go! to Sleep, General Sleep Education
Keywords
cognitive behavioral therapy for insomnia, randomized controlled trial
Medical subject headings
Sleep Initiation and Maintenance Disorders, Coronary Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Go! to SleepBehavioural

    Also called web-based cognitive behavioral therapy

    This is an online interactive program that delivers cognitive behavioral therapy for insomnia via the internet.

  • General Sleep EducationBehavioural

    Providing patients information on healthy sleep and habits to promote healthy sleep.

Study groups in NCT02848859
Study groupRoleWhat they receive
Intervention: Go! to SleepActive comparatorWe are using a web-based cognitive behavioral therapy program called Go! to Sleep. Go! to Sleep is an interactive online program developed by specialists in Cleveland Clinic's Wellness Institute and Sleep Disorders Center. The program is a 6 week self-help program that uses cognitive behavioral therapy techniques that have been proven to be effective in decreasing symptoms of insomnia.
Receives: Behavioral: Go! to Sleep; Behavioral: General Sleep Education
General Sleep Hygiene EducationPlacebo comparatorGeneral Sleep Hygiene Education is the first step in the treatment of any sleep disorder. Both arms will have access to a Harvard sleep education web site that provides general information about sleep as well as sleep hygiene.
Receives: Behavioral: General Sleep Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline Insomnia Severity Index score at 6 weeks

    It is a 7 item, validated questionnaire to determine severity of insomnia symptoms.

    Measured: At baseline, at 6 weeks, and in the treatment arm at 12 weeks.

Secondary outcomes (6)
  1. Change in sleep duration from baseline to 6 weeks

    The investigators will use sleep diaries that participants fill out for 1 week at baseline and at 6 weeks to compare sleep duration between arms as well as at 12 weeks in the treatment arm only to assess duration of treatment effect.

    Measured: At baseline, at 6 weeks, and in the treatment arm at 12 weeks.

  2. Change in mood assessed using the Patient Health Questionnaire-8 from baseline to 6 weeks

    The investigators will use the Patient Health Questionnaire-8 to measure depressive symptoms

    Measured: At baseline, at 6 weeks, and in the treatment arm at 12 weeks.

  3. Change in sleepiness assessed using the Epworth Sleepiness Questionnaire from baseline to 6 weeks

    The investigators will use the Epworth Sleepiness questionnaire to measure sleepiness.

    Measured: At baseline, at 6 weeks, and in the treatment arm at 12 weeks.

  4. Change in blood pressure from baseline to 6 weeks

    The investigators will measure seated blood pressure in triplicate and use the average of the latter two readings for blood pressure (taken at baseline and 6 week visits).

    Measured: At baseline and at 6 weeks

  5. Change in heart rate from baseline to 6 weeks

    The investigators will measure seated heart rate in triplicate and use the average of the latter two readings for heart rate(taken at baseline and 6 week visits).

    Measured: At baseline and at 6 weeks

  6. Change in Quality of life at baseline and 6 weeks

    The investigators will measure this using the Duke Health Profile, another validated questionnaire to measure quality of life.

    Measured: At baseline, at 6 weeks, and in the treatment arm at 12 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2016 (estimated)
  2. Study startMar 2015
  3. Primary completionDec 2015
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02848859
Sponsor's protocol ID
2014P000845
Status last verified
Feb 2017
First submitted
22 Jul 2016
Last updated
23 Feb 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Go! to Sleep and General Sleep Education in people with Insomnia and Coronary Heart Disease, run by Brigham and Women's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline Insomnia Severity Index score at 6 weeks (time frame: At baseline, at 6 weeks, and in the treatment arm at 12 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in